Neuland Laboratories is a leading manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end chemistry-related solutions provider for the pharmaceutical industry. With three FDA-inspected facilities, 846+ DMFs, 1000+ employees and customers in more than 85 countries, Neuland supports some of the world’s best-known and most successful …
Bharat Biotech International Limited is a multidimensional biotechnology company specializing in product-oriented research and development leading to the manufacture of vaccines and bio-therapeutics in Hyderabad, India. Bharat Biotech was established in the year 1996 by Dr. Krishna M. Ella and Mrs. Suchitra K. Ella. Bharat Biotech …
Senores Pharmaceuticals and Dr. Reddy’s Laboratories announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and therapeutically equivalent to STROMECTOL Tablets of Merck Sharp and Dohme LLC in the U.S. market. The product will be marketed by Dr. Reddy’s. “We are pleased to …
Shilpa Medicare’s Joint Venture Oncosol (50:50 JV with Liqmeds Lifecare Limited, a Zydus group company and Koana Healthcare Limited, Shilpa Medicare group company) along with its partner Shorla Oncology announces that the USFDA has approved IMKELDI (imatinib oral solution), the first oral liquid form of imatinib …
IMMACULE – (MANUFACTURER OF LIQUID AND LYOPHILIZED INJECTIONS). Approvals – UK-MHRA, ANVISA, PICS, INVIMA, US FDA* Immacule provides world-class expertise in Lyophilized products with consistency in quality, delivery and competive pricing. Our state-of-the-art manufacturing facility is designed to comply with regulated markets pricing and Our global …
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Travoprost Ophthalmic Solution USP, 0.004% (Ionic Buffered Solution). Glenmark’s Travoprost Ophthalmic Solution USP, 0.004% is bioequivalent and therapeutically equivalent to the reference listed drug, Travatan Z Ophthalmic Solution USP, 0.004% of Sandoz. According to IQVIATM sales data …
Ad Blocker Detected
Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.
error: Content is protected !!
